Category Archives: Pharmaceutical

What You Didn’t Know About Dr. Clay Siegall and his Role in Seattle Genetics

For the likes of Dr. Clay Siegall, passion is a great skill that goes hand in hand with succeeding in any business venture. In an interview with Inspirery, the successful doctor said that his passion for improving the healthcare sector is what saw him launch Seattle Genetics. Also, Dr. Siegall earlier lost a relative to cancer what he attributed to the pain caused by the chemotherapy. According to Siegall, the chemotherapies needed some improvement, a thing that also saw the launch of Seattle Genetics besides the money part.

In an interview with Inspirery, the CEO of Seattle Genetics said that his firm generates great revenue from selling their own proprietary drugs which are doing well. Also, the company earns an income from licensing technologies and processes they have developed. When questioned about his profitable journey, Siegall said to Inspirery that it took almost a decade to comfortably enjoy the profits of his venture.

In any form of business, it is the customer who brings business and not the other way round. Dr. Clay Siegall understood this and that’s why in the early 2000s, he brought in staff with not only hard work but with a deep understanding in biotech, a field of their specialization. Also, Seattle Genetics releases great and unique products that go selling themselves. Besides, Seattle Genetics utilizes the skills of great legal team to strike promising deals to the firm.

About Dr. Clay Siegall

Dr. Clay Siegall is the co-founder of Seattle Genetics and serves as its President, chief executive officer, and the chairman of the board. Siegall is renowned for his scientific emphasis on targeted cancer treatments. As stated earlier, Dr. Siegall has a passion in improving the healthcare sector particularly the cancer field. Through his motivation, Dr. Siegall has driven Seattle Genetics to the leading position it stands today. Through partnerships with Takeda Pharmaceutical Company, ADCETRIS has circulated global in more than 65 countries.

Under Siegall’s leadership, Seattle has entered into multiple strategic licenses for its ADC technology, all which generate lots of revenue. Before founding Seattle Genetics, Dr. Siegall was at Bristol-Myers Squibb Pharmaceutical Research Institute. He had joined this institute in 1991 and served for about six years. Also, Siegall served at the National Cancer Institute, National Institute of Health.

Today, Dr. Siegall serves on the board of Ultragenyx Pharmaceutical, Alder BioPharmaceuticals, and also the Washington Roundtable. Siegall’s effort and impact on the society would never go unrecognized. In 2013, the successful doctor was acknowledged as the University of Maryland Alumnus among others. Besides his busy schedules, Siegall is a distinguished author and has written over 70 publications.